SepehrRokhsarMD

PubMed

• 75 citations
  A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer.
  Richard Tuli, Stephen L. Shiao, Nicholas N. Nissen, Mourad Tighiouart, Sungjin Kim, Arsen Osipov, Miranda Bryant, Lindsey Ristow, Veronica Placencio-Hickok, David M. J...> ;Ebiomedicine. 2019 Feb 1
• 23 citations
  Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas
  Munevver Cinar, Fred P. Rosenfelt, Sepehr Rokhsar, Jean Lopategui, Raju Pillai, Melissa Cervania, Andy Pao, Bekir Cinar, Serhan Alkan> ;Leukemia Research. 2015 Jul 1
• 5 citations
  Intestinal stoma complications in immunocompromised children
  Sepehr Rokhsar, Elizabeth A. Harrison, Donald B. Shaul, J.Duncan Phillips> ;Journal of Pediatric Surgery. 1999 Dec 1
• 16 citations
  Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction
  Marcelo F. Di Carli, Farbod Asgarzadie, Heinrich R. Schelbert, Richard C. Brunken, Sepehr Rokhsar, Jamshid Maddahi> ;Journal of Nuclear Cardiology. 1998 Nov 1
• 57 citations
  Risk Factors for Early Infection of Central Venous Catheters in Pediatric Patients
  Donald B. Shaul, Bryan Scheer, Sepehr Rokhsar, Valerie A Jones, Linda S. Chan, Beth A Boody, Marcio H. Malogolowkin, Wilbert H. Mason> ;Journal of the American College of Surgeons. 1998 Jun 1
• Join now to see all